Dose distribution and up-titration patterns of metformin monotherapy in patients with type 2 diabetes (scientific article published on 17 December 2019)

Comparative Effectiveness of Metformin Dosage Uptitration Versus Adding Another Antihyperglycemic Medication on Glycemic Control in Type 2 Diabetes Patients Failing Initial Metformin Monotherapy: A Retrospective Cohort Study

Q90979725

Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes

Q91068483

Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase-4 inhibitors in treatment-naïve patients with type 2 diabetes in Japan

Q92402694

Data Resource Profile: Clinical Practice Research Datalink (CPRD)

Q28645951

Adaptation and validation of the Charlson Index for Read/OXMIS coded databases

Q33522043

Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus

Q33763380

Trends in Prescription Drug Use Among Adults in the United States From 1999-2012.

Q34500310

Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013

Q35763657

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes

Q35927578

Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study

Q36038607

Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.

Q36972693

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

Q37141727

Exploring reasons for very poor glycaemic control in patients with Type 2 diabetes

Q37904147

Overview of metformin: special focus on metformin extended release

Q38024861

Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes

Q38524435

Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.

Q38620148

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

Q38645266

Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014.

Q38848552

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

Q39913264

Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study

Q40273819

Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database

Q40892456

Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study

Q45389552

Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries

Q50133598

Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes.

Q51501042

Adherence to hypoglycaemic medication among people with type 2 diabetes in primary care

Q56835602

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Q56979722

Global Guideline for Type 2 Diabetes

Q59372334

The prescription pattern of initial treatment for type 2 diabetes in Beijing from 2011 to 2015

Q64113080

Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink.

Q64934457

P433

issue

P921

main subject

metformin

Q19484

type 2 diabetes

Q3025883

P304

page(s)

e00107